Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-23-000028

Options or other derivatives

  • Director acquired 39,062 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cahill Thomas Director 2023-06-14 Grant or award · Stock Option (right to buy) +39,062 39,062 D
Loading xslF345X04/wf-form4_168695226752131.xml…